AUGUST 10, 2021


NCODA Structures Medically Integrated Pharmacy Accreditation


Cazenovia, New York – As the leading not-for-profit association for the patient-centered medically-integrated oncology community, NCODA, Inc. is excited to announce the new NCODA Center of Excellence (CoE) Medically Integrated Pharmacy (MIP) Accreditation Program. The program, based on compliance with the ASCO/NCODA Patient-Centered Standards for Medically Integrated Dispensing, focuses on enhanced patient care and quality of services. An Executive Accreditation Council and an Accreditation Working Group will provide guidance, insight and support for the new CoE MIP Accreditation Program.

“NCODA’s focus from day one has been patient-centered; to always deliver quality, value and financial viability resources to medically integrated oncology centers that will in turn enhance patient care,” said Jim Schwartz, RPh, NCODA Executive Council President. “Providing this Center of Excellence accreditation will only accelerate our Mission to bring the best care possible to every cancer patient and improve overall outcomes.”

Elizabeth Bell, NCODA’s Director of Medically Integrated Pharmacy Accreditation, will lead this initiative and work closely with both the Accreditation Executive Council and the Accreditation Working Group. Bell has over twenty years experience in healthcare accreditation, compliance and management. Elizabeth has managed quality and accreditation departments, developed healthcare quality initiatives and led statewide compliance audit teams. Most recently she served as the VP of Consulting Services for a healthcare accreditation consulting company.

“We are thrilled to have Elizabeth lead this program,” said Michael Reff, NCODA Executive Director. “Elizabeth’s background aligns perfectly to NCODA’s Mission and we look forward to how she will use her previous experience to enhance our resources to the benefit of our patients, our members and all stakeholders in the oncology community.”

NCODA holds itself accountable to serving the medically integrated dispensing community by delivering positive, patient-centered resources and programs to ensure the highest of quality and best practice standards are provided to the patient. NCODA set out on this accreditation process as a commitment to empower oncology centers to deliver the highest level of performance that brings sustainability and value. Over the past several months, program groundwork has been laid and gained great support from stakeholders including: community and health system oncology practices, pharmaceutical partners, professional and advocacy organizations, as well as PBMs and plans. Further details on NCODA’s Center of Excellence (CoE) Medically Integrated Pharmacy (MIP) Accreditation Program will be announced in the coming weeks.





NCODA, Inc. is a 501(c)(3) organization. Our Mission is to empower the medically-integrated oncology team to deliver positive, patient-centered outcomes by providing leadership, expertise, quality standards and best practices. For more information about NCODA’s Executive Council and general updates, visit